New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Repeated teen cannabis use may disrupt dopamine-related brain development, MRI data suggest

Repeated teen cannabis use may disrupt dopamine-related brain development, MRI data suggest

byBrown UniversityCharacteristics of regions in which 1/nT2* was measured. Credit:Neuropsychopharmacology(2026). DOI: 10.1038/s41386-026-02444-9A new study from Bradley Hospital researchers shows that
Psychiatry & Mental Health June 21,2026
Repeated teen cannabis use may disrupt dopamine-related brain development, MRI data suggest

Repeated teen cannabis use may disrupt dopamine-related brain development, MRI data suggest

byBrown UniversityCharacteristics of regions in which 1/nT2* was measured. Credit:Neuropsychopharmacology(2026). DOI: 10.1038/s41386-026-02444-9A new study from Bradley Hospital researchers shows that
Psychiatry & Mental Health June 21,2026
AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

byUniversity of CambridgeThe super antigen is compatible with most vaccine delivery systems. In this trial it was administered as DNA vaccine through a microfluid jet. This needle-free delivery method
Public Health & Prevention June 21,2026
AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

byUniversity of CambridgeThe super antigen is compatible with most vaccine delivery systems. In this trial it was administered as DNA vaccine through a microfluid jet. This needle-free delivery method
Public Health & Prevention June 21,2026
New insights into how autistic and non-autistic people learn about one another

New insights into how autistic and non-autistic people learn about one another

byGeorge Washington UniversityPreference learning paradigm. Credit:Nature Mental Health(2026). DOI: 10.1038/s44220-026-00650-4New research from the George Washington University has yielded some unexpe
Psychiatry & Mental Health June 21,2026
New insights into how autistic and non-autistic people learn about one another

New insights into how autistic and non-autistic people learn about one another

byGeorge Washington UniversityPreference learning paradigm. Credit:Nature Mental Health(2026). DOI: 10.1038/s44220-026-00650-4New research from the George Washington University has yielded some unexpe
Psychiatry & Mental Health June 21,2026
Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks

Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks

byUniversity Medical Center UtrechtESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo: (A) Mean ESSDAI corrected for baseline, indicating the treatment effect of l
Immunology & Rheumatology June 21,2026
Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks

Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks

byUniversity Medical Center UtrechtESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo: (A) Mean ESSDAI corrected for baseline, indicating the treatment effect of l
Immunology & Rheumatology June 21,2026
The price of winning at all costs—well-being in high-performance sport

The price of winning at all costs—well-being in high-performance sport

byVictoria University of WellingtonCredit: Victoria University of WellingtonIn high-performance sport, success is often measured in medals, rankings and results, but far less attention is paid to the
Orthopedics & Sports medicine June 21,2026
The price of winning at all costs—well-being in high-performance sport

The price of winning at all costs—well-being in high-performance sport

byVictoria University of WellingtonCredit: Victoria University of WellingtonIn high-performance sport, success is often measured in medals, rankings and results, but far less attention is paid to the
Orthopedics & Sports medicine June 21,2026
First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
Hematology&Oncology June 20,2026
First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
Hematology&Oncology June 20,2026
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu
Hematology&Oncology June 20,2026
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu
Hematology&Oncology June 20,2026
Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000
Hematology&Oncology June 20,2026
Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000
Hematology&Oncology June 20,2026
Strongest evidence yet that vaping likely causes cancer

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth
Hematology&Oncology June 20,2026
Strongest evidence yet that vaping likely causes cancer

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth
Hematology&Oncology June 20,2026
Molecular test for bile duct cancer nearly doubles detection rate

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de
Hematology&Oncology June 19,2026
Molecular test for bile duct cancer nearly doubles detection rate

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de
Hematology&Oncology June 19,2026
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com